Statement of Federal Trade Commission Chairman Jon Leibowitz on Ending “Pay-for-Delay” Drug Settlements, Praises Inclusion in President’s Health Care Proposal
admin | Feb 22, 2010
“When drug companies agree not to compete, consumers lose,” said Federal Trade Commission Chairman Jon Leibowitz.
Related Posts:
- Julie Brill Begins Term at Federal Trade Commission
- Edith Ramirez Sworn In as Federal Trade Commissioner
- Statement from Federal Trade Commission Chairman Jon Leibowitz on Senate confirmation of new FTC Commissioners
- FTC and States Attorneys General to Announce Major Identity Theft Initiative
- Commission Approves FY 2011 Budget Request and GPRA Performance Plans for Submission to Congress; FTC Staff: Proposed Kentucky Regulations for Licensing Retail Clinics Raise Competitive Concerns; FTC Issues Annual Financial Acts Enforcement Report to Federal Reserve
Filed Under: Antitrust - Fraud





